Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001104659-24-022538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-13 | 2024-02-09+ | RYTM | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | — | +5,469 | 6,459 | +552% | — |
| DM | 2024-02-13 | 2024-02-12+ | RYTM | Lee Jennifer Kayden | EVP, Head of North America | S - Sale+OE | $50.80 | -1,638 | 7,467 | -18% | -$83.2K |
| DM | 2024-02-13 | 2024-02-09+ | RYTM | Lee Jennifer Kayden | EVP, Head of North America | M - OptEx | $0.00 | -5,469 | 2,031 | -73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-11 | M | A | 2,031 | — | 8,490 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Common | Common Stock | 2024-02-09 | M | A | 3,438 | — | 6,459 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 3 | Common | Common Stock | 2024-02-13 | S | D | 615 | $49.83 | 6,852 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-12 | S | D | 1,023 | $51.38 | 7,467 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2024-02-09 | M | D | 3,438 | $0.00 | 6,874 | D | — · — to — | 3,438 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date. |
| 6 | Derivative | Restricted Stock Units | 2024-02-11 | M | D | 2,031 | $0.00 | 2,031 | D | — · — to — | 2,031 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F4) The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. |